Alexander Gregor

Alexander Gregor

Auto-generated profile, based on publicly available information

Alexander Gregor

Division of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2022 in Biomaterials
Verified
Journal Article
Closed access
JLJenny Lou
Jenny Lou
MAMasato Aragaki
Masato Aragaki
NBNicholas Bernards
Nicholas Bernards
TCTess Chee
Tess Chee
AGAlexander Gregor
Alexander Gregor
GZGang Zheng
Gang Zheng

3 August 2021 in Nanophotonics
Verified
Journal Article
Open access
PDF file
JLJenny Lou
Jenny Lou
MAMasato Aragaki
Masato Aragaki
NBNicholas Bernards
Nicholas Bernards
TKTomonari Kinoshita
Tomonari Kinoshita
JMJessica Mo
Jessica Mo
KYKazuhiro Yasufuku
Kazuhiro Yasufuku
While photodynamic therapy (PDT) can induce acute inflammation in the irradiated tumor site, a sustained systemic, adaptive immune response is desirable, as it may control the growth of nonirradiated distant disease. Previously, we developed porphyrin lipoprotein (PLP), a ∼20 nm nanoparticle photosensitizer, and observed that it not only efficiently eradicated irradiated primary VX2 buccal carcinomas in rabbits, but also induced regression of nonirradiated metastases in a draining lymph node. We hypothesized that PLP‐mediated PDT can induce an abscopal effect and we sought to investigate the immune mechanism underlying such a response in a highly aggressive, dual subcutaneous AE17‐OVA+ mesothelioma model in C57BL/6 mice. Four cycles of PLP‐mediated PDT was sufficient to delay the growth of a distal, nonirradiated tumor four‐fold relative to controls. Serum cytokine analysis revealed high interleukin‐6 levels, showing a 30‐fold increase relative to phosphate‐buffered solution (PBS) treated mice. Flow cytometry revealed an increase in CD4+ T cells and effector memory CD8+ T cells in non‐irradiated tumors. Notably, PDT in combination with PD‐1 antibody therapy prolonged survival compared to monotherapy and PBS. PLP‐mediated PDT shows promise in generating a systemic immune response that can complement other treatments, improving prognoses for patients with metastatic cancers.

22 April 2020 in Respirology
Verified
Journal Article
Open access
PDF file
AGAlexander Gregor
Alexander Gregor
TITerunaga Inage
Terunaga Inage
BHBin Hwangbo
Bin Hwangbo
KYKazuhiro Yasufuku
Kazuhiro Yasufuku
Implementation of lung cancer screening and improvements in imaging are expected to increase the proportion of lung cancer diagnosed at an early stage. The standard of care has historically been anatomic lobectomy; however, there is now an array of surgical and non‐surgical approaches for management of local disease either in active use or under investigation. By their nature, these new modalities offer a theoretical trade‐off of reduced morbidity in exchange for reduced efficacy in the setting of advanced disease. It is therefore critical that patients being considered for these approaches (e.g. surgical segmentectomy and SABR) be accurately staged to maximize the potential for definitive treatment. In this article, we will review current approaches to the staging of patients being considered for segmentectomy or ablation. This will serve as a foundation to highlight important questions deserving further investigation.

29 March 2023 in Biomedical Physics & Engineering Express
Verified
Journal Article
Open access
AEAndrew Effat
Andrew Effat
NBNicholas Bernards
Nicholas Bernards
AGAlexander Gregor
Alexander Gregor
EYEdmond W K Young
Edmond W K Young
KYKazuhiro Yasufuku
Kazuhiro Yasufuku
RWRobert A Weersink
Robert A Weersink
Objective. Laser interstitial thermal therapy (LITT) is an evolving hyperthermia-based technology that may offer a minimally invasive alternative to inoperable lung cancer. LITT of perivascular targets is challenged by higher risk of disease recurrence due to vascular heat sinks, as well as risk of damage to these vascular structures. The objective of this work is to examine the impact of multiple vessel parameters on the efficacy of the treatment and the integrity of the vessel wall in perivascular LITT. Approach. A finite element model is used to examine the role of vessel proximity, flow rate, and wall thickness on the outcome of the treatment. Main result. The simulated work indicates that vessel proximity is the major factor in driving the magnitude of the heat sink effect. Vessels situated near the target volume may act as a protective measure for reducing healthy tissue damage. Vessels with thicker walls are more at risk of damage during treatment. Interventions to reduce the flow rate may reduce the vessel’s heat sink effect but may also result in increased risk of vascular wall damage. Lastly, even at reduced blood flow rates, the volume of blood reaching the threshold of irreversible damage (>43 °C) is negligible compared to the volume of blood flow throughout the treatment duration. Significance. This investigative simulation yields results that may help guide clinicians on treatment planning near large vessels.

29 December 2019 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
AGAlexander Gregor
Alexander Gregor
KFKosuke Fujino
Kosuke Fujino
NBNicholas Bernards
Nicholas Bernards
TKTomonari Kinoshita
Tomonari Kinoshita
YMYamato Motooka
Yamato Motooka
KYKazuhiro Yasufuku
Kazuhiro Yasufuku
Background: The rabbit squamous cell cancer line, VX2, has been used to generate various tumor models in rabbits. It is notable for its ability to generate nodal metastases. However, the timing and extent of nodal metastases vary by primary inoculation site and methodology. The development of metastases specifically in lung cancer models has not been well-described. We sought to characterize the generation of nodal metastases in rabbit transbronchial VX2 lung tumor models. Methods: Rabbit VX2 lung tumor models were created in the right lung via transbronchial injection and serially imaged by computed tomography. Rabbits (n = 15) were sacrificed from between 5 and 24 days post-inoculation for collection of the ipsilateral and contralateral paratracheal lymph nodes. These underwent histopathological evaluation for metastases using hematoxylin and eosin as well as cytokeratin AE1/AE3 immunohistochemical staining. Results: Nodal metastases were detectable as early as 1 week after inoculation but were more prevalent with longer inoculation; all rabbits at > 2 weeks post-inoculation had nodal metastases. Contralateral metastases were in general seen later than ipsilateral metastases. Lymph node volume did not predict the likelihood of nodal metastases (p = 0.4 and p = 0.07 for ipsilateral and contralateral nodal metastases, respectively), but primary tumor volume was significantly associated with the likelihood of nodal metastases (p = 0.001 and p = 0.005 for ipsilateral and contralateral nodal metastases, respectively). Ipsilateral metastases were detectable at a tumor diameter of 1 cm; contralateral metastases were more variable but in general required a tumor diameter of 2 cm. Conclusions: Rabbit transbronchial VX2 lung tumor models generate nodal metastases relatively early after inoculation. These results suggest such models may be valuable tools in the investigation of novel therapeutic modalities relevant for the treatment of both early-stage and locally advanced lung cancer.

1 November 2022 in Current Challenges in Thoracic Surgery
Verified
Journal Article
Open access
PDF file
AGAlexander Gregor
Alexander Gregor
TITsukasa Ishiwata
Tsukasa Ishiwata
TITerunaga Inage
Terunaga Inage
KYKazuhiro Yasufuku
Kazuhiro Yasufuku
Narrative review—how to access nodules: role of new technology including navi- and robo-bronchoscopy Alexander Gregor, Tsukasa Ishiwata, Terunaga Inage, Kazuhiro Yasufuku